Adaptimmune Therapeutics (473A) Q2 2026 Earnings Report
DE:473A Q2 2026 EPS Results
- Actual EPS
- ―
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.10
DE:473A Q2 2026 Revenue Results
- Actual Revenue
- ―
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/12/2026
- Time
- TBA
- Conference Call
- Wednesday, August 12, 2026
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:473A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 12, 2026 | 2026 (Q2) | ―- | -0.1 | ― | |
| May 20, 2026 | 2026 (Q1) | -0.03- | -0.03 | ― | |
| Mar 10, 2026 | 2025 (Q4) | -0.05-0.03 | -0.04 | 40.00% (+0.02) | |
| Nov 05, 2025 | 2025 (Q3) | -0.11- | -0.01 | ― | |
| Aug 13, 2025 | 2025 (Q2) | -0.04-0.02 | 0.04 | -150.00% (-0.05) | |
| May 13, 2025 | 2025 (Q1) | -0.08-0.03 | -0.03 | 0.00% (+0.00) | |
| Mar 20, 2025 | 2024 (Q4) | -0.03-0.04 | -0.04 | -25.00% (-0.01) | |
| Nov 13, 2024 | 2024 (Q3) | -0.01-0.01 | -0.03 | 66.67% (+0.02) | |
| Aug 12, 2024 | 2024 (Q2) | -0.040.04 | -0.02 | 300.00% (+0.05) | |
| May 15, 2024 | 2024 (Q1) | -0.14-0.03 | 0 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
